Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The main goal of this trial is to study the efficacy of Namisol® after a single dose of
Δ9-THC in the treatment of pain resulting from chronic pancreatitis. Objective measures of
pain processing, e.g. encephalography (EEG) and quantitative sensory testing (QST), are
included to provide insight in underlying nociceptive processing.